• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性肾脏病患儿蛋白质能量消耗的危险因素分析]

[Risk factors analysis of protein energy wasting in children with chronic kidney disease].

作者信息

Liang Y, Jiang Y P, Wang H, Zhou N, Fu Q, Shen Y

机构信息

Department 2 of Nephrology, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing Key Laboratory for Chronic Renal Disease and Blood Purification, Key Laboratory of Major Diseases in Children, National Center for Children's Health, Beijing 100045, China.

出版信息

Zhonghua Er Ke Za Zhi. 2023 Sep 2;61(9):794-798. doi: 10.3760/cma.j.cn112140-20230502-00309.

DOI:10.3760/cma.j.cn112140-20230502-00309
PMID:37650160
Abstract

To analyze the clinical characteristics and risk factors of protein energy wasting (PEW) in children with chronic kidney disease (CKD). Clinical data of 231 children with chronic kidney disease hospitalized in Beijing Children's Hospital affiliated to Capital Medical University from January 2018 to January 2023 were retrospectively analyzed to explore the incidence of PEW. According to the diagnostic criteria of CKDPEW, they were divided into a CKDPEW group and a non PEW group. The comparison between the groups was performed by independent-sample test and Chi-squared test, and the risk factors were analyzed by multivariate Logistic regression. Among the 231 children, there were 138 males and 93 females, with a visiting age of 9.9 (7.9, 16.0) years; 6 cases were in stage 1, 14 cases in stage 2, 51 cases in stage 3, 36 cases in stage 4, and 124 cases in stage 5. A total of 30 children (13.0%) with CKD PEW were diagnosed at the age of 7. 1 (3.8, 13.2) years, including 1 case in stage 1, 1 case in stage 2, 5 cases in stage 3, 5 cases in stage 4, and 18 cases in stage 5. There were a total of 201 cases (87.0%) in the non PEW group, diagnosed at the age of 11.8 (8.5, 12.2) years, including 5 cases in stage 1, 13 cases in stage 2, 46 cases in stage 3, 31 cases in stage 4, and 106 cases in stage 5. The Chi-squared test and test showed that the systolic blood pressure, diastolic blood pressure, birth weight and carbon dioxide binding capacity of the CKD PEW group were lower than those of the non PEW group ((109±22) (120±20) mmHg (1 mmHg=0.133 kPa), (72±19) (79±16) mmHg, (2.9±0.5) (3.2±0.6) kg, (17±4) (19±4) mmol/L,=2.85, 2.14, 0.67, 2.63, all 0.05). Multivariate logistic regression analysis showed that carbon dioxide binding capacity and birth weight were independent protective factors of CKDPEW in children (=0.81 and 0.36, 95%=0.73-0.90 and 0.17-0.77, respectively; both 0.01); the risk of PEW in CKD children decreased by 0.187 times for every 1 mmol/L increment in carbon dioxide binding capacity, and 0.638 times for every 1 kg increment in birth weight. The incidence of protein energy expenditure in children with chronic kidney disease is lower than that in the previous researches. PEW can appear in CKD 1-2 stage, and attention should be paid to it in the early stage of CKD in clinical practice. Low birth weight CKD children are susceptible to PEW, and actively correcting metabolic acidosis can reduce the risk of CKDPEW.

摘要

分析慢性肾脏病(CKD)患儿蛋白质能量消耗(PEW)的临床特征及危险因素。回顾性分析2018年1月至2023年1月在首都医科大学附属北京儿童医院住院的231例慢性肾脏病患儿的临床资料,以探讨PEW的发生率。根据CKD-PEW的诊断标准,将其分为CKD-PEW组和非PEW组。采用独立样本t检验和卡方检验进行组间比较,并通过多因素Logistic回归分析危险因素。231例患儿中,男138例,女93例,就诊年龄为9.9(7.9,16.0)岁;1期6例,2期14例,3期51例,4期36例,5期124例。共30例(13.0%)CKD-PEW患儿诊断时年龄为7.1(3.8,13.2)岁,其中1期1例,2期1例,3期5例,4期5例,5期18例。非PEW组共201例(87.0%),诊断时年龄为11.8(8.5,12.2)岁,其中1期5例,2期13例,3期46例,4期31例,5期106例。卡方检验和t检验显示,CKD-PEW组的收缩压、舒张压、出生体重和二氧化碳结合力均低于非PEW组((109±22) (120±20)mmHg(1 mmHg = 0.133 kPa),(72±19) (79±16)mmHg,(2.9±0.5) (3.2±0.6)kg,(17±4) (19±4)mmol/L,t = 2.85、2.14、0.67、2.63,均P<0.05)。多因素Logistic回归分析显示,二氧化碳结合力和出生体重是儿童CKD-PEW的独立保护因素(β = -0.81和-0.36,95%CI分别为-0.90至-0.73和-0.77至-0.17;均P<0.01);CKD患儿二氧化碳结合力每增加1 mmol/L,PEW风险降低0.187倍,出生体重每增加1 kg,PEW风险降低0.638倍。慢性肾脏病患儿蛋白质能量消耗的发生率低于以往研究。PEW可出现在CKD 1-2期,临床实践中CKD早期应予以关注。低出生体重的CKD患儿易发生PEW,积极纠正代谢性酸中毒可降低CKD-PEW的风险。

相似文献

1
[Risk factors analysis of protein energy wasting in children with chronic kidney disease].[慢性肾脏病患儿蛋白质能量消耗的危险因素分析]
Zhonghua Er Ke Za Zhi. 2023 Sep 2;61(9):794-798. doi: 10.3760/cma.j.cn112140-20230502-00309.
2
Cross-sectional relationship between dietary protein intake, energy intake and protein energy wasting in chronic kidney disease patients.横断面研究显示慢性肾脏病患者的饮食蛋白摄入、能量摄入与蛋白能量消耗之间的关系。
Br J Nutr. 2024 Aug 14;132(3):309-314. doi: 10.1017/S0007114524001041. Epub 2024 May 31.
3
Body cell mass estimation by whole body potassium counter and its association with protein energy wasting in Indian children with chronic kidney disease.通过全身钾计数器估算身体细胞质量及其与印度慢性肾病儿童蛋白质能量消耗的关联。
Pediatr Nephrol. 2025 Aug;40(8):2619-2626. doi: 10.1007/s00467-025-06739-9. Epub 2025 Mar 17.
4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
5
Increasing Trends of Pediatric Thoracic and Lumbar Spine Fractures in the United States from 2004 to 2023: A 20-year National Injury Review Depicting Shifts in Mechanisms of Injury.2004年至2023年美国儿童胸腰椎骨折的增长趋势:一项为期20年的全国性损伤回顾,描绘损伤机制的变化
Clin Orthop Relat Res. 2025 Feb 25. doi: 10.1097/CORR.0000000000003421.
6
Blood pressure targets for hypertension in people with chronic renal disease.高血压合并慢性肾脏病患者的血压目标。
Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
9
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.